MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines

Cancer Research

Volumn 57, Issue 23, 1997, Pages 5221-5225

  Teng, David H F ^a,d   Hu, Rong ^a   Lin, Huai ^b   Davis, Thaylon ^a   Iliev, Diana ^a   Frye, Cheryl ^a   Swedlund, Brad ^a   Hansen, Kipp L ^a   Vinson, Vickie L ^a   Gumpper, Kathryn L ^a   Ellis, Lee ^b   El Naggar, Adel ^b   Frazier, Marsha ^b   Jasser, Samar ^b   Langford, Lauren A ^b   Lee, Jeff ^b   Mills, Gordon B ^b   Pershouse, Mark A ^b   Pollack, Raphael E ^b   Tornos, Carmen ^b   Troncoso, Patricia ^b   Yung, W K Alfred ^b   Fujii, Gregory ^c   Berson, Amy ^c   Bookstein, Robert ^c   Bolen, Joseph B ^c   Tavtigian, Scan V ^a   Steck, Peter A ^b   more..

^a Myriad Genetics Laboratories Inc   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d Myriad Genetic Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASTROCYTOMA; CHROMOSOME 10Q; CHROMOSOME 9; GENE EXPRESSION; GENE MUTATION; GLIOBLASTOMA; HETEROZYGOSITY; HUMAN; HUMAN CELL; MELANOMA; MISSENSE MUTATION; NONSENSE MUTATION; PRIORITY JOURNAL; PSEUDOGENE; TUMOR SUPPRESSOR GENE;

BRAIN NEOPLASMS; BREAST NEOPLASMS; CHILD; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 10; EXONS; FEMALE; GENE DELETION; GENETIC MARKERS; GLIOBLASTOMA; GLIOMA; HUMANS; INTRONS; KIDNEY NEOPLASMS; MALE; MUTATION; NEOPLASMS; PHOSPHORIC MONOESTER HYDROLASES; POINT MUTATION; PROSTATIC NEOPLASMS; PROTEIN-TYROSINE-PHOSPHATASE; PTEN PHOSPHOHYDROLASE; SEQUENCE DELETION; TESTICULAR NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; VARIATION (GENETICS);

EID: 14444269482     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., Fyre, C., Hu, R., Swedlund, B., Teng, D. H. F., and Tavtigian, S. Identification of a candidate tumor suppressor gene. MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet., 15: 356-362, 1997.
2. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S. H., Giovanella, B. C., Ittmann, M., Tycko, B., Hibhoosh, H., Wigler, M. H., and Parsons, R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science (Washington DC), 275: 1943-1947, 1997.
3. Myers, M. P., Stolarov, J. P., Eng, C., Li, J., Wang, S. I., Wigler, M. H., Parsons, R., and Tonks, N. K. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc. Natl. Acad. Sci. USA, 94: 9052-9057, 1997.
4. Li, D-M., and Sun, H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor β. Cancer Res., 57: 2124-2129, 1997.
5. Liaw, D., Marsh, D. J., Li, J., Dahia, P. L. M., Wang, S. I., Zheng, Z., Bose, S., Call, K. H., Tsou, H. C., Peacocke, M., Eng, C., and Parsons, R. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet., 16: 64-67, 1997.
6. Nelen, M. R., van Staveren, W. C. G., Peeters, E. A. J., Hassel, M. B., Gorlin, R. J., Hamm, H., Lindboe, C. F., Fryns, J-P., Sijmons, R. H., Woods, D. G., Mariman, E. C. M., Padberg, G. W., and Kremer, H. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum. Mol. Genet., 6: 1383-1387, 1997.
7. Tsou, H. C., Teng, D. H-F., Ping, X. L., Brancolini, V., Davis, T., Hu, R., Xie, X-X., Gruener, A. C., Schrager, C. A., Christiano, A. M., Eng, C., Steck, P., Ott, J., Tavtigian, S. V., and Peacocke, M. Role of MMAC1 mutations in early onset breast cancer: causative in association with Cowden's syndrome and excluded in BRCA1-negative cases. Am. J. Hum. Genet., in press, 1997.
8. Marsh, D. J., Dahia, P. L. M., Zheng, Z., Liaw, D., Parsons, R., Gorlin, R. J., and Eng, C. Germline mutations in PTEN ar present in Bannayan-Zonana syndrome. Nat. Genet., 16: 333-334, 1997.
9. Pershouse, M. A., El-Naggar, A. K., Hurr, K., Lin, H., Yung, W. K. A., and Steck, P. A. Deletion mapping of chromosome 4 in head and neck squamous cell carcinoma. Oncogene, 14: 369-373, 1997.
10. Steck, P. A., Hadi, A., Cheong, H. C., Yung, W. K. A., and Pershouse, M. A. Evidence for two tumor suppressive loci on chromosome 10 involved in glioblastomas. Genes Chromosomes Cancer, 12: 255-261, 1995.
11. Teng, D. H. F., Bogden, R., Mitchell, J., Baumgard, M., Bell, R., Berry, S., Davis, T., Ha, P. C., Kehrer, R., Jammulapati, S., Chen, Q., Offit, K., Skolnick, M. H., Tavtigian, S. V., Jhanwar, S., Swedlund, B., Wong, A. K. C., and Kamb, A. Low incidence of BRCA2 mutation in breast carcinoma and other cancers. Nat. Genet., 13: 241-248, 1996.
12. Collins, A., Frezal, J., Teague, J., and Morton, N. E. A metric map of humans: 23,500 loci in 850 bands. Proc. Natl. Acad. Sci. USA, 93: 14771-14775, 1996.
13. Teng, D. H-F., Perry, W., Hogan, J. K., Baumgard, M., Bell, R., Berry, S., Davis, T., Frank, D., Frye, C., Hattier, T., Hu, R., Jammulapati, S., Janecki, T., Leavitt, A., Mitchell, J. T., Pero, R., Sexton, D., Schroeder, M., Su, P. H., Swedlund, B., Kyriakis, J., Avruch, J., Bartel, P., Wong, A. K. C., Oliphant, A., Thomas, A., Skolnick, M. H., and Tavtigian, S. V. Human MAP kinase kinase 4 as a candidate tumor suppressor. Cancer Res., 57: 4177-4182, 1997.
14. Ananthaswamy, H. N., and Pierceall, W. E. Molecular mechanisms of ultraviolet radiation carcinogenesis. Photochem. Photobiol., 52: 1119-1136, 1990.
15. Ziegler, A., Jonason, A., Simon, J., Leffell, D., and Brash, D. E. Tumor suppressor gene mutations and photocarcinogenesis. Photochem. Photobiol., 63: 432-435, 1996.
16. Herbst, R. A., Weiss, J., Ehnis, A., Cavenee, W. K., and Arden, K. C. Loss of heterozygosity for 10q22-qter in malignant melanoma progression. Cancer Res., 54: 3111-3114, 1994.
17. Ittmann, M. Allelic loss on chromosome 10 in prostate adenocarcinoma. Cancer Res., 56: 2143-2147, 1996.
18. Rempel, S. A., Schwechheimer, K., Davis, R. L., Cavenee, W. K., and Rosenblum, M. L. Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression. Cancer Res., 53: 2386-2392, 1993.
19. Murakami, Y. S., Albertsen, H., Brothman, A. R., Leach, R. J., and White, R. L. Suppression of the malignant phenotype of human prostate cancer cell line PPC-1 by introduction of normal fragments of human chromosome 10. Cancer Res., 56: 2157-2160, 1996.
20. Denu, J., Stuckey, J. A., Saper, D., and Dixon, J. E. Form and function in protein dephosphorylation. Cell, 87: 361-364, 1996.
21. Tonks, N. K., and Neel, B. G. From form to function: signaling by protein tyrosine phosphatases. Cell, 87: 365-368, 1996.
22. Songyang, Z., and Cantely, L. C. Recognition and specificity in protein tyrosine kinase mediated signalling. Trends Biochem. Sci., 20: 470-475, 1995.
23. Hardie, G., and Hanks, S. The Protein Kinase Facts Book. Protein-Serine Kinases. London: Academic Press, 1995.
24. Fanning, A. S., and Anderson, J. M. Protein-protein interactions: PDZ domain networks. Curr. Biol., 6: 1385-1388, 1996.
25. Saras, J., and Heldin, C-H. PDZ domains bind carboxy-terminal sequences of target proteins. Trends Biochem. Sci., 21: 455-458, 1996.